• Eczema
  • COPD Move
  • CRD Closing banner
  • Banner Child

    Putting you at the centre of all decisions affecting your health

  • Banner map

    30% of the European population lives with allergies, asthma and COPD

  • Banner hands

    Because breathing is taken for granted, we work for better recognition of chronic respiratory diseases

EMA recommends more education materials on the use of adrenaline auto-injectors
The European Medicines Agency (EMA) has recommended several measures to ensure that patients and carers use adrenaline auto-injectors successfully. Among the measures, EMA suggests introducting more e ...

Read more

Information on herbal medicines will now be accessible to patients
From now on the European Medicines Agency (EMA) will systematically publish summaries of the recommendations of its Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of a herbal ...

Read more

European Union launches new logo for selling medicines online
As from 1 July 2015, all online pharmacies or online shop selling medicines in the EU must display a new logo to show they are operating legally. The was introduced through the Falsified Medicines Dir ...

Read more

Patients’ input in research: the soonest and the deepest, the better
The involvement of patients in research projects is often limited to the participation in clinical trials or other forms of research where patients provide samples. To overcome this common limitation, ...

Read more

Patient Access to Innovative Therapies - EAPM Conference
On the 2nd and 3rd June EFA representative Breda Flood participated at the European Alliance for Personalised Medicine (EAPM) Presidency Conference 'Smaller Members And Regions Together ...

Read more

Medicines initiative opens the way for more patient involvement
IMI (Innovative Medicines Initiative) is Europe's largest public-private initiative seeking to speed up the development of better and safer medicines for patients. This year’s IMI forum counted on m ...

Read more

Save the Date: MeDALL Results Symposium
We are pleased to announce on behalf of the MeDALL Consortium the celebration of the event “Are Europeans developing more allergies? – From research to policies”, an event at the European Parliam ...

Read more

EU Policy update (April 2015)
Launch of Interest Group on Allergy and Asthma: EFA/EAACI REPORT The European Parliament Interest Group on Allergy and Asthma was launched on the 25th of March. The event was co-hosted by the Inte ...

Read more

EU Policy update (March 2015)
March was full of novelties! WHO published a report on the access to new medicines in Europe and the EEA published the State of the Environment linking environmental policies to our health. The Commis ...

Read more

EFA in events (March 2015)
Much new evidence of interest for allergy, asthma and COPD patients was published in March. We attended the launch of the EMA 20th years anniversary, the Roadmap for sustainable care, the EEA State of ...

Read more

Press Release: EP Interest Group on Allergy and Asthma
Launch of new European Parliament Interest Group on Allergy and Asthma Brussels, 25 March, 2015 – Members of the European Parliament (MEPs), patients, doctors have joined forces in an Interest Group ...

Read more

EU Policy Update (October 2014)
October was busy in Europe! The new European Commission was approved by the European Parliament, the discussion on the Clean Air Package is getting more intense, the European Medicines Agency improved ...

Read more

EU Policy update (Summer 2014)
New leaders of the European Institutions We left you before the summer break with updates on the composition of the new European Parliament coming out from the elections of May 2014. As from July, i ...

Read more

EFA Training on EMA
EFA training for patient experts on allergy, asthma and COPD on getting involved with the European Medicines Agency (EMA) As we informed you in the last issue of our eZine, EFA planned to host on 18 ...

Read more

EFA training on involvement with the EMA
Rationale: 12 patient experts from EFA member associations will have the opportunity to discover what the European Medicines Agency (EMA) is and especially how patients can be involved in its activiti ...

Read more

New EMA Video: The Black Triangle
EMA has just published new informative materials on "black triangle" which is the sign that identifies medicines that are being monitored particularly closely. A video on the topic is available with t ...

Read more

EMA Workshop: Best expertise vs conflicts of interests
This workshop is intended to elicit the views and concerns from academia, patient organisations, Committee representatives, non-governmental organisations, the pharmaceutical industry and the scientif ...

Read more

EFA at the PCWP of the European Medicines Agency (EMA)
On the 28th of February, EFA attended one of the periodical joint meetings of the PCWP and the Healthcare Professionals’ Working Group (HCP WG) at the EMA in London. EFA, which has been taking part in ...

Read more

EFA at EMA meetings
On 30th November EFA board member Lina Buzermaniene and EFA COPD advisor Michael Wilken took part in the Patients and Consumers Working Party (PCWP) meeting at the European Medicines Agency (EMA), whi ...

Read more

EMA adopts implementation plan for its 'Road map to 2015'
The management board of the European Medicines Agency (EMA) has adopted a new document entitled "Implementing the European Medicines Agency's Road map to 2015: The Agency's contribution to Science, Me ...

Read more